Overview
We respond to the compelling need for a technological
shift towards more accurate and sustainable breast
cancer diagnostics with cutting-edge AI technology,
customer proximity, and lean regulatory strategy. We
expect new job opportunities and competitive know-how
for the Swiss medtech industry.